Quantcast

Latest Protein expression Stories

2011-02-24 00:00:45

The National Science Foundation grant—administered through the Small Business Innovation Research Program (SBIR)—will enable DNA2.0 to extend the company’s proven gene optimization technology to production hosts for human therapeutics. Menlo Park, CA (PRWEB) February 23, 2011 DNA2.0, the leading gene synthesis and protein engineering company, has been awarded a National Science Foundation (NSF) grant to further the company’s research into gene optimization...

2010-01-07 09:00:00

IPSWICH, Mass., Jan. 7 /PRNewswire/ -- New England Biolabs (NEB) has introduced Lemo21(DE3) Competent E. coli, a tunable T7 expression strain optimized for the expression of difficult constructs, including membrane proteins, toxic proteins and proteins prone to insoluble expression.